CVS HEALTH Corp SEC filings CVS

CVS HEALTH Corp has 1,003 filings in SEC EDGAR's recent list, going back to Dec 19, 2017. Its latest annual report, Form ARS, was filed on Apr 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

CVS HEALTH Corp SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Regulation FD disclosure
Nov 4, 2026 Nov 4, 2026
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 17, 2026 Aug 13, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2026 —
13F-HR Filing Aug 6, 2026 Jun 30, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
4 Insider transaction Jun 29, 2026 Jun 26, 2026
11-K Employee savings plan report Jun 23, 2026 Dec 31, 2025
4 Insider transaction Jun 1, 2026 May 31, 2026
4 Insider transaction Jun 1, 2026 May 31, 2026
4 Insider transaction May 22, 2026 May 20, 2026
144 Notice of proposed sale May 22, 2026 —
S-8 Employee stock plan registration May 22, 2026 —
S-3ASR Automatic shelf registration May 22, 2026 —
4 Insider transaction May 21, 2026 May 19, 2026
144 Notice of proposed sale May 21, 2026 —
8-K Current report
Officer or director change, Shareholder vote results
May 18, 2026 May 14, 2026
4 Insider transaction May 15, 2026 May 14, 2026
4 Insider transaction May 15, 2026 May 14, 2026
4 Insider transaction May 15, 2026 May 14, 2026
4 Insider transaction May 15, 2026 May 14, 2026
4 Insider transaction May 15, 2026 May 14, 2026
4 Insider transaction May 15, 2026 May 14, 2026
4 Insider transaction May 15, 2026 May 14, 2026
4 Insider transaction May 15, 2026 May 14, 2026
4 Insider transaction May 15, 2026 May 14, 2026
4 Insider transaction May 15, 2026 May 14, 2026
4 Insider transaction May 15, 2026 May 14, 2026
4 Insider transaction May 15, 2026 May 14, 2026
4 Insider transaction May 11, 2026 May 8, 2026
144 Notice of proposed sale May 8, 2026 —
13F-HR Filing May 7, 2026 Mar 31, 2026
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 6, 2026 May 6, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2026 —
ARS Annual report to shareholders Apr 3, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 3, 2026 —
DEF 14A Proxy statement Apr 3, 2026 May 14, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
4 Insider transaction Mar 20, 2026 Mar 19, 2026
3 Initial insider ownership Mar 19, 2026 Mar 19, 2026
8-K Current report
Officer or director change
Mar 19, 2026 Mar 18, 2026
4 Insider transaction Mar 2, 2026 Feb 28, 2026
4 Insider transaction Mar 2, 2026 Feb 28, 2026
13F-HR Filing Feb 13, 2026 Dec 31, 2025
10-K Annual report Feb 10, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 10, 2026 Feb 10, 2026
4 Insider transaction Jan 27, 2026 Jan 23, 2025
4 Insider transaction Jan 5, 2026 Jan 1, 2026
8-K Current report
Regulation FD disclosure
Dec 9, 2025 Dec 9, 2025
4 Insider transaction Dec 2, 2025 Dec 1, 2025
4 Insider transaction Dec 2, 2025 Nov 30, 2025
4 Insider transaction Dec 2, 2025 Nov 30, 2025
4 Insider transaction Dec 2, 2025 Nov 30, 2025
4 Insider transaction Nov 21, 2025 Nov 20, 2025
4 Insider transaction Nov 21, 2025 Nov 20, 2025
4 Insider transaction Nov 21, 2025 Nov 20, 2025
4 Insider transaction Nov 21, 2025 Nov 20, 2025
4 Insider transaction Nov 21, 2025 Nov 20, 2025
4 Insider transaction Nov 21, 2025 Nov 20, 2025
4 Insider transaction Nov 21, 2025 Nov 20, 2025
4 Insider transaction Nov 21, 2025 Nov 20, 2025
4 Insider transaction Nov 21, 2025 Nov 20, 2025
4 Insider transaction Nov 21, 2025 Nov 20, 2025
4 Insider transaction Nov 21, 2025 Nov 20, 2025
8-K Current report
Other events
Nov 20, 2025 Nov 20, 2025
3/A Primary document Nov 7, 2025 May 19, 2025
13F-HR Filing Oct 31, 2025 Sep 30, 2025
10-Q Quarterly report Oct 29, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 29, 2025 Oct 29, 2025
4 Insider transaction Oct 14, 2025 Sep 9, 2024
3/A Primary document Oct 14, 2025 Sep 9, 2024
8-K Current report
Other events
Sep 22, 2025 Sep 22, 2025
4 Insider transaction Sep 2, 2025 Aug 31, 2025
4 Insider transaction Sep 2, 2025 Aug 31, 2025
4 Insider transaction Aug 29, 2025 Aug 20, 2025
144 Notice of proposed sale Aug 19, 2025 —
8-K Current report
Other events
Aug 15, 2025 Aug 11, 2025
424B2 Prospectus Aug 12, 2025 —
FWP Free writing prospectus Aug 12, 2025 —
424B3 Prospectus Aug 11, 2025 —
13F-HR Filing Aug 1, 2025 Jun 30, 2025
10-Q Quarterly report Jul 31, 2025 Jun 30, 2025
8-K Current report
Results of operations
Jul 31, 2025 Jul 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 16, 2025 —
11-K Employee savings plan report Jun 26, 2025 Dec 31, 2024
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 3, 2025 May 31, 2025
4 Insider transaction Jun 3, 2025 May 31, 2025
3 Initial insider ownership May 27, 2025 May 19, 2025
3 Initial insider ownership May 21, 2025 May 12, 2025
8-K Current report
Shareholder vote results
May 20, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
SCHEDULE 13G Ownership over 5% (passive) May 13, 2025 —
4/A Primary document May 9, 2025 Apr 1, 2025
4 Insider transaction May 6, 2025 May 2, 2025
13F-HR Filing May 2, 2025 Mar 31, 2025
10-Q Quarterly report May 1, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 1, 2025 May 1, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 17, 2025 —
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 8, 2025 Apr 7, 2025
ARS Annual report to shareholders Apr 4, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 4, 2025 —
DEF 14A Proxy statement Apr 4, 2025 May 15, 2025
4 Insider transaction Apr 3, 2025 Apr 1, 2025
4 Insider transaction Apr 3, 2025 Apr 1, 2025
4 Insider transaction Apr 3, 2025 Apr 1, 2025
4 Insider transaction Apr 3, 2025 Apr 1, 2025
4 Insider transaction Apr 3, 2025 Apr 1, 2025
4 Insider transaction Apr 3, 2025 Apr 1, 2025
4 Insider transaction Apr 3, 2025 Apr 1, 2025
4 Insider transaction Apr 3, 2025 Apr 1, 2025
4 Insider transaction Mar 18, 2025 Mar 17, 2025
4 Insider transaction Mar 14, 2025 Nov 18, 2022
4 Insider transaction Mar 7, 2025 Mar 5, 2025
144 Notice of proposed sale Mar 5, 2025 —
4 Insider transaction Mar 3, 2025 Feb 28, 2025
4 Insider transaction Mar 3, 2025 Feb 28, 2025
4 Insider transaction Mar 3, 2025 Feb 28, 2025
4 Insider transaction Feb 19, 2025 Feb 18, 2025
13F-HR Filing Feb 13, 2025 Dec 31, 2024
10-K Annual report Feb 12, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 12, 2025 Feb 12, 2025
4/A Primary document Dec 26, 2024 Nov 30, 2024
8-K Current report
Other events
Dec 17, 2024 Dec 16, 2024
8-K Current report
Other events
Dec 10, 2024 Dec 10, 2024
4 Insider transaction Dec 9, 2024 Dec 5, 2024
8-K Current report
Other events
Dec 9, 2024 Dec 9, 2024
8-K Current report
Other events
Dec 6, 2024 Dec 6, 2024
424B2 Prospectus Dec 5, 2024 —
8-K Current report
Other events
Dec 5, 2024 Dec 3, 2024
FWP Free writing prospectus Dec 4, 2024 —
4 Insider transaction Dec 3, 2024 Nov 30, 2024
4 Insider transaction Dec 3, 2024 Nov 30, 2024
4 Insider transaction Dec 3, 2024 Nov 30, 2024
4 Insider transaction Dec 3, 2024 Nov 30, 2024
4 Insider transaction Dec 3, 2024 Nov 30, 2024
4 Insider transaction Dec 3, 2024 Nov 30, 2024
4 Insider transaction Dec 3, 2024 Nov 30, 2024
424B3 Prospectus Dec 3, 2024 —
8-K Current report
Other events
Dec 2, 2024 Dec 2, 2024
4 Insider transaction Nov 25, 2024 Nov 21, 2024
4 Insider transaction Nov 25, 2024 Nov 21, 2024
4 Insider transaction Nov 25, 2024 Nov 21, 2024
4 Insider transaction Nov 25, 2024 Nov 21, 2024
3 Initial insider ownership Nov 25, 2024 Nov 17, 2024
4 Insider transaction Nov 25, 2024 Nov 21, 2024
3 Initial insider ownership Nov 25, 2024 Nov 17, 2024
3 Initial insider ownership Nov 25, 2024 Nov 17, 2024
3 Initial insider ownership Nov 25, 2024 Nov 17, 2024
4 Insider transaction Nov 25, 2024 Nov 21, 2024
4 Insider transaction Nov 25, 2024 Nov 21, 2024
4 Insider transaction Nov 25, 2024 Nov 21, 2024
4 Insider transaction Nov 25, 2024 Nov 21, 2024
4 Insider transaction Nov 25, 2024 Nov 21, 2024
4 Insider transaction Nov 25, 2024 Nov 21, 2024
4 Insider transaction Nov 25, 2024 Nov 21, 2024
4 Insider transaction Nov 25, 2024 Nov 21, 2024
4 Insider transaction Nov 25, 2024 Nov 21, 2024
UPLOAD Letter from the SEC Nov 21, 2024 —
CORRESP Letter to the SEC Nov 21, 2024 —
UPLOAD Letter from the SEC Nov 19, 2024 —
8-K Current report
Material agreement, Officer or director change, Regulation FD disclosure
Nov 18, 2024 Nov 12, 2024
3 Initial insider ownership Nov 15, 2024 Nov 6, 2024
SC 13G Ownership over 5% (passive) Nov 13, 2024 —
13F-HR Filing Nov 8, 2024 Sep 30, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Nov 6, 2024 Nov 6, 2024
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 6, 2024 Nov 6, 2024
SC 13G/A Amended ownership over 5% (passive) Oct 24, 2024 —
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
Oct 18, 2024 Oct 17, 2024
3 Initial insider ownership Sep 19, 2024 Sep 9, 2024
4 Insider transaction Sep 3, 2024 Aug 31, 2024
13F-HR Filing Aug 9, 2024 Jun 30, 2024
10-Q Quarterly report Aug 7, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 7, 2024 Aug 7, 2024
11-K Employee savings plan report Jun 20, 2024 Dec 31, 2023
S-8 Employee stock plan registration May 23, 2024 —
8-K Current report
Officer or director change, Shareholder vote results
May 22, 2024 May 16, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Retail-Drug Stores and Proprietary Stores (SIC 5912)
Listed as
CVS (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Woonsocket, RI
SEC filer status
Large accelerated filer
SEC CIK
64803
Former names
CVS CAREMARK CORP (until Sep 3, 2014); CVS/CAREMARK CORP (until May 8, 2007); CVS CORP (until Mar 22, 2007); MELVILLE CORP (until Jan 10, 1997)

Other Retail-Drug Stores and Proprietary Stores companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.